Glaucoma Therapeutics Market to Reach USD 11.05 Billion at 6.1% CAGR by 2027

Posted on Sep 21 2022 9:54 AM

"Glaucoma Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027"

The global “Glaucoma Therapeutics Market Size" is expected to rise with an impressive CAGR and generate the highest revenue by 2027. Fortune Business Insights™ in its latest report published this information. The report is titled " Glaucoma Therapeutics Market Size, Share & Trends, 2027". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period.

The global glaucoma therapeutics market size was USD 6.59 billion in 2019 and is projected to reach USD 11.05 billion by 2027, exhibiting a CAGR of 6.1% during the forecast period.

To understand long -term and short-term impact of COVID-19 on this market, Get Sample Report:

The report evaluates the important characteristics of the market based on present industry scenarios, market demands and business strategies. Also, the research report separates the industry based on the Glaucoma Therapeutics Market share, types, applications, growth factor, key players and regions.

Drivers & Restraints

There is currently an increasing prevalence of glaucoma among the elderly population. The increasing screen time of gadgets such as laptops and smart phones among the geriatric population is further aiding in the rising incidence of glaucoma. According to the International Agency of the Prevention of Blindness, in 2018, around 1.9% of the U.S. population above 40 years of age has glaucoma. The Agency also estimates that by 2020, around 80 million people will suffer from glaucoma globally.                                                              


Prostaglandins Analogs Segment to Grow Rapidly Backed by Fewer Side Effects

Based on product type, the market is fragmented into combination drugs, carbonic anhydrase inhibitors, beta blockers, alpha adrenergic agonists, prostaglandins analogs, and others. Out of these, the prostaglandins analogs segment earned 40.3% in terms of glaucoma therapeutics market share in 2019. This growth is attributable to their possession of fewer side effects, unlike the other glaucoma therapeutics. They are also efficient in lowering intraocular pressure (IOP).                    

Key Players:

  • Merck & Co., Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Allergan plc (part of AbbVie Inc.) (Ireland)
  • Bausch and Lomb Incorporated (U.S.)
  • Teva Pharmaceuticals Industry (Israel)
  • Pfizer, Inc. (U.S.)
  • Aerie Pharmaceuticals (U.S.)
  • Inotek Pharmaceuticals (U.S.)
  • Other Prominent Players

Purchase Full Report:

COVID-19 Outbreak Impact Analysis on Glaucoma Therapeutics Market

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

The COVID-19 outbreak has spawned widespread economic distress and uncertainty, with many industries, markets, and businesses undergoing tremendous stress. However, together, the global community can tide over these challenging times and at Fortune Business Insights™, we aim to provide precise market intelligence through extensive and intensive research into the impact of this pandemic on various businesses.

Primary Research:

Various sources from both the supply and demand sides were interviewed during the primary research process to obtain qualitative and quantitative information for this report. Primary sources included industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations from all segments of the value chain of this industry.

To obtain and verify critical qualitative and quantitative information, in-depth interviews were conducted with a variety of primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants.

Glaucoma Therapeutics Market Introduction, Overview, and In-depth industry analysis:

  • Top key players with their business strategy, sales volume, and revenue analysis
  • Latest technological developments
  • Robust facts and factors research methodology
  • Regional analysis with graphical representation of size, share & trends
  • Market trends, obstacles and growth drivers
  • Includes list of table & figures

Highlights of the Glaucoma Therapeutics Market Report:

  • Market Development: Comprehensive information about emerging industry. This report analyses for various segments across geographies
  • Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the industry.
  • Market Diversification: Exhaustive information about new launching, untapped geographies, recent developments, and investments in the market 

Major table of contents:

  • Glaucoma Therapeutics Market Introduction and Market Overview
  • Research Regions
  • Research Scope and Market Size Estimation
  • Industry Trends
  • Drivers
  • Future Challenges
  • Market Restraints
  • Market Segmentation
  • Research Methodology
  • Market Dynamics
  • Glaucoma Therapeutics Market Development Trends under COVID-19 Outbreak
  • Global Revenue and Growth Rate
  • Industry News and Policies by Regions
  • Concentration Ratio and Market Maturity Analysis
  • Merger, Acquisitions, and Partnerships
  • Porter’s Five Forces Analysis
  • PEST Analysis
  • Applications

TOC Continued………

Speak to Analyst:

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.


Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.


US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

LinkedIn Facebook Twitter